Mitoxantrone (Mitoxantrone)

Mitoxantrone is a drug that is used to treat certain types of cancers, including breast cancer, leukemia and lymphomas.

Mitoxantrone has antitumor activity due to the inhibition of topoisomerase II enzymes, which are involved in DNA replication in rapidly dividing tumor cells. This leads to disruption of the process of cell division and their death.

Mitoxantrone is used both as monotherapy and in combination with other anticancer drugs. It is effective in the treatment of advanced and metastatic breast cancer, acute leukemia and non-Hodgkin's lymphoma.

Side effects of mitoxantrone are usually mild and include nausea, vomiting, hair loss, and decreased blood cell counts. In rare cases, heart failure may develop.

Mitoxantrone is available as a concentrate for the preparation of a solution for intravenous administration. Its trade name is Novantrone.

Mitoxantrone is a drug that is used to treat certain types of cancer, including breast cancer, leukemia and lymphomas.

Mitoxantrone has antitumor activity by inhibiting the growth and proliferation of tumor cells. It interacts with cell DNA, disrupting the processes of replication and transcription, which leads to the death of cancer cells.

This medicine is used to treat both acute and chronic forms of leukemia and also to treat non-Hodgkin's lymphomas. In addition, mitoxantrone is used in combination with other anticancer drugs for breast cancer.

Side effects when using mitoxantrone are usually mild. The most common are nausea, vomiting, loss of appetite, and hair loss. In rare cases, cardiotoxicity may develop.

Mitoxantrone is available as a concentrate for the preparation of a solution for intravenous infusion. Its trade name is Novantrone.

**Mitoxantrone** is a drug with an antitumor effect. It is prescribed for successful antitumor therapy in various forms and conditions of cancer. Thanks to mitoxantrone, patients can again feel like a healthy person, having lived for some time without deterioration. The effect becomes noticeable after the first dose of the drug is administered. By acting on tumor cells, it stops their viability and inhibits growth. In addition, the drug controls tissue nutrition. Its use allows you to completely relieve the pressure that the cancerous tumor puts on the organ.

Mitaxantrone belongs to group a